BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murakami R, Nishimura R, Baba Y, Yumoto E, Oya N, Yamashita Y. Concurrent chemoradiation therapy with low-dose CDDP and UFT for glottic carcinomas: Evaluation using the sixth edition of the UICC TNM staging system. Acta Oncologica 2009;45:162-7. [DOI: 10.1080/02841860500490269] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Fesneau M, Pointreau Y, Chapet S, Martin L, Pommier P, Alfonsi M, Laguerre B, Feham N, Berger C, Garaud P, Calais G. Concomitant Chemoradiotherapy Using Carboplatin, Tegafur-Uracil and Leucovorin for Stage III and IV Head-and-Neck Cancer: Results of GORTEC Phase II Study. International Journal of Radiation Oncology*Biology*Physics 2010;76:154-63. [DOI: 10.1016/j.ijrobp.2009.01.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Nomura T, Murakami R, Toya R, Teshima K, Nakahara A, Hirai T, Hiraki A, Nakayama H, Yoshitake Y, Ota K, Obayashi T, Yamashita Y, Oya N, Shinohara M. Phase II Study of Preoperative Concurrent Chemoradiation Therapy With S-1 in Patients With T4 Oral Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2010;76:1347-52. [DOI: 10.1016/j.ijrobp.2009.03.055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
3 Tong CC, Au KH, Ngan RK, Cheung FY, Chow SM, Fu YT, Au JS, Law SC. Definitive radiotherapy for early stage glottic cancer by 6 MV photons. Head Neck Oncol 2012;4:23. [PMID: 22607730 DOI: 10.1186/1758-3284-4-23] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
4 Ono T, Tanaka N, Chitose SI, Tanoue S, Kurita T, Sueyoshi S, Fukahori M, Miyata Y, Muraki K, Tsuji C, Ogo E, Hattori C, Sato K, Abe T, Umeno H. Comparative Treatment Outcome in T3N0 Glottic Cancer With and Without Vocal Fold Fixation Receiving Radiation Therapy and Concurrent Low-Dose Intra-Arterial Cisplatin Infusion. Ann Otol Rhinol Laryngol 2021;:34894211047789. [PMID: 34565187 DOI: 10.1177/00034894211047789] [Reference Citation Analysis]
5 Riga M, Chelis L, Danielides V, Vogiatzaki T, Pantazis TL, Pantazis D. Systematic review on T3 laryngeal squamous cell carcinoma; still far from a consensus on the optimal organ preserving treatment. Eur J Surg Oncol 2017;43:20-31. [PMID: 27320417 DOI: 10.1016/j.ejso.2016.05.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
6 Kim BH, Park SJ, Jeong WJ, Ahn SH. Comparison of Treatment Outcomes for T3 Glottic Squamous Cell Carcinoma: A Meta-Analysis. Clin Exp Otorhinolaryngol 2018;11:1-8. [PMID: 29486540 DOI: 10.21053/ceo.2017.00717] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
7 Toya R, Murakami R, Murakami D, Saito T, Matsuyama T, Toya Y, Yamashita Y, Oya N. Radiotherapy for T3N0 glottic carcinoma without cord fixation: elective nodal irradiation or not? Oncotarget 2017;8:79761-6. [PMID: 29108356 DOI: 10.18632/oncotarget.19337] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]